132 related articles for article (PubMed ID: 13679209)
1. Thiazolidinediones inhibit cell growth of human oral squamous cell carcinoma in vitro independent of peroxisome proliferator-activated receptor gamma.
Nakashiro K; Begum NM; Uchida D; Kawamata H; Shintani S; Sato M; Hamakawa H
Oral Oncol; 2003 Dec; 39(8):855-61. PubMed ID: 13679209
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibition through activation of peroxisome proliferator-activated receptor gamma in human oesophageal squamous cell carcinoma.
Hashimoto Y; Shimada Y; Itami A; Ito T; Kawamura J; Kawabe A; Kaganoi J; Maeda M; Watanabe G; Imamura M
Eur J Cancer; 2003 Oct; 39(15):2239-46. PubMed ID: 14522385
[TBL] [Abstract][Full Text] [Related]
3. Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.
Begum NM; Nakashiro K; Kawamata H; Uchida D; Shintani S; Ikawa Y; Sato M; Hamakawa H
Int J Oncol; 2002 Mar; 20(3):599-605. PubMed ID: 11836575
[TBL] [Abstract][Full Text] [Related]
4. Role of peroxisome proliferator-activated receptor gamma and its ligands in non-neoplastic and neoplastic human urothelial cells.
Nakashiro KI; Hayashi Y; Kita A; Tamatani T; Chlenski A; Usuda N; Hattori K; Reddy JK; Oyasu R
Am J Pathol; 2001 Aug; 159(2):591-7. PubMed ID: 11485917
[TBL] [Abstract][Full Text] [Related]
5. Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation.
Ellis CN; Varani J; Fisher GJ; Zeigler ME; Pershadsingh HA; Benson SC; Chi Y; Kurtz TW
Arch Dermatol; 2000 May; 136(5):609-16. PubMed ID: 10815854
[TBL] [Abstract][Full Text] [Related]
6. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
[TBL] [Abstract][Full Text] [Related]
7. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
[TBL] [Abstract][Full Text] [Related]
8. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
[TBL] [Abstract][Full Text] [Related]
11. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth of pancreatic cancers both in vitro and in vivo.
Itami A; Watanabe G; Shimada Y; Hashimoto Y; Kawamura J; Kato M; Hosotani R; Imamura M
Int J Cancer; 2001 Nov; 94(3):370-6. PubMed ID: 11745416
[TBL] [Abstract][Full Text] [Related]
12. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
Shimada T; Kojima K; Yoshiura K; Hiraishi H; Terano A
Gut; 2002 May; 50(5):658-64. PubMed ID: 11950812
[TBL] [Abstract][Full Text] [Related]
14. Thiazolidinediones inhibit growth of gastrointestinal, biliary, and pancreatic adenocarcinoma cells through activation of the peroxisome proliferator-activated receptor gamma/retinoid X receptor alpha pathway.
Tsujie M; Nakamori S; Okami J; Hayashi N; Hiraoka N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Exp Cell Res; 2003 Sep; 289(1):143-51. PubMed ID: 12941612
[TBL] [Abstract][Full Text] [Related]
15. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells.
Toyoda M; Takagi H; Horiguchi N; Kakizaki S; Sato K; Takayama H; Mori M
Gut; 2002 Apr; 50(4):563-7. PubMed ID: 11889080
[TBL] [Abstract][Full Text] [Related]
16. Expression of PPARgamma and its ligand-dependent growth inhibition in human brain tumor cell lines.
Kato M; Nagaya T; Fujieda M; Saito K; Yoshida J; Seo H
Jpn J Cancer Res; 2002 Jun; 93(6):660-6. PubMed ID: 12079514
[TBL] [Abstract][Full Text] [Related]
17. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
[TBL] [Abstract][Full Text] [Related]
18. 15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells.
Nikitakis NG; Siavash H; Hebert C; Reynolds MA; Hamburger AW; Sauk JJ
Br J Cancer; 2002 Dec; 87(12):1396-403. PubMed ID: 12454768
[TBL] [Abstract][Full Text] [Related]
19. PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity.
Takashima T; Fujiwara Y; Higuchi K; Arakawa T; Yano Y; Hasuma T; Otani S
Int J Oncol; 2001 Sep; 19(3):465-71. PubMed ID: 11494023
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition of esophageal squamous carcinoma cells by peroxisome proliferator-activated receptor-gamma ligands.
Rumi MA; Sato H; Ishihara S; Ortega C; Kadowaki Y; Kinoshita Y
J Lab Clin Med; 2002 Jul; 140(1):17-26. PubMed ID: 12080324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
